Coastal Investment Advisors, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Coastal Investment Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$4.93 - $9.31 $6,670 - $12,596	-1,353 Reduced 8.97%	13,738 $68,000
Q4 2023 Jan 19, 2024	SELL	$7.13 - $9.49 $18,195 - $24,218	-2,552 Reduced 14.46%	15,091 $135,000
Q4 2022 Feb 10, 2023	SELL	$4.11 - $8.14 $12,050 - $23,866	-2,932 Reduced 14.25%	17,643 $76,000
Q3 2022 Oct 27, 2022	SELL	$6.66 - $12.39 $4,582 - $8,524	-688 Reduced 3.24%	20,575 $155,000
Q2 2022 Aug 09, 2022	SELL	$8.95 - $12.8 $2,953 - $4,224	-330 Reduced 1.53%	21,263 $242,000
Q1 2022 Apr 13, 2022	BUY	$10.05 - $22.48 $44,943 - $100,530	4,472 Added 26.12%	21,593 $267,000
Q2 2021 Jul 15, 2021	SELL	$10.0 - $14.52 $5,500 - $7,986	-550 Reduced 3.11%	17,121 $222,000
Q1 2021 Apr 12, 2021	BUY	$12.3 - $18.73 $73,111 - $111,331	5,944 Added 50.69%	17,671 $229,000
Q4 2020 Jan 13, 2021	BUY	$12.94 - $16.05 $4,606 - $5,713	356 Added 3.13%	11,727 $162,000
Q3 2020 Oct 23, 2020	BUY	$13.19 - $16.66 $149,983 - $189,440	11,371 New	11,371 $167,000
Q1 2020 Apr 23, 2020	SELL	$11.34 - $21.46 $121,780 - $230,458	-10,739 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $65,078 - $82,045	10,739 New	10,739 $70,000

210

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.